JP5759464B2 - オキサリプラチンのナノ粒子及びその製造方法 - Google Patents
オキサリプラチンのナノ粒子及びその製造方法 Download PDFInfo
- Publication number
- JP5759464B2 JP5759464B2 JP2012530778A JP2012530778A JP5759464B2 JP 5759464 B2 JP5759464 B2 JP 5759464B2 JP 2012530778 A JP2012530778 A JP 2012530778A JP 2012530778 A JP2012530778 A JP 2012530778A JP 5759464 B2 JP5759464 B2 JP 5759464B2
- Authority
- JP
- Japan
- Prior art keywords
- oxaliplatin
- nanoparticles
- lipid
- oral administration
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2009-0089079 | 2009-09-21 | ||
| KR20090089079 | 2009-09-21 | ||
| PCT/KR2010/006459 WO2011034394A2 (ko) | 2009-09-21 | 2010-09-20 | 옥살리플라틴의 나노 입자 및 이를 제조하는 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013505291A JP2013505291A (ja) | 2013-02-14 |
| JP5759464B2 true JP5759464B2 (ja) | 2015-08-05 |
Family
ID=43759199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012530778A Expired - Fee Related JP5759464B2 (ja) | 2009-09-21 | 2010-09-20 | オキサリプラチンのナノ粒子及びその製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9393201B2 (https=) |
| EP (1) | EP2481396A4 (https=) |
| JP (1) | JP5759464B2 (https=) |
| KR (1) | KR101396461B1 (https=) |
| CN (1) | CN102665689B (https=) |
| AU (1) | AU2010296180B2 (https=) |
| CA (1) | CA2774669C (https=) |
| IN (1) | IN2012DN02576A (https=) |
| MX (1) | MX348668B (https=) |
| RU (1) | RU2563997C2 (https=) |
| WO (1) | WO2011034394A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2983490A1 (en) * | 2013-03-15 | 2016-02-17 | DSM IP Assets B.V. | Solid lipid nanoparticles (ii) |
| AU2018255063A1 (en) * | 2017-04-21 | 2018-11-22 | Bio-Synectics Inc. | Method for preparing active material nanoparticles using lipid as lubricant for milling |
| KR101895237B1 (ko) * | 2017-06-12 | 2018-09-07 | 목포대학교산학협력단 | 옥살리플라틴을 포함하는 경구용 약물전달 조성물 및 이의 제조방법 |
| KR102184117B1 (ko) * | 2017-10-31 | 2020-11-30 | 주식회사 삼양바이오팜 | 수용해도 및 생체이용율이 개선된 소라페닙 나노입자 경구용 조성물 및 이의 제조 방법 |
| ES2927608T3 (es) | 2018-09-14 | 2022-11-08 | Inst Nat Sante Rech Med | Sistema de liberación de fármacos para fármacos basados en platino |
| CN110917345B (zh) * | 2019-09-26 | 2021-11-09 | 苏州百迈生物医药有限公司 | 一种化疗免疫组合药物及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2989695A (en) * | 1994-08-08 | 2000-03-07 | Debiopharm S.A. | Pharmaceutically stable oxaliplatinum preparation |
| FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| CN1191067C (zh) * | 1997-02-05 | 2005-03-02 | 法玛西雅厄普约翰美国公司 | 高不溶性铂配合物的脂质复合物和脂质体 |
| GB9804013D0 (en) | 1998-02-25 | 1998-04-22 | Sanofi Sa | Formulations |
| US7217735B1 (en) * | 1999-04-09 | 2007-05-15 | Au Jessie L-S | Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| JP2003524624A (ja) * | 1999-04-09 | 2003-08-19 | ジェシー エル エス オウ | 治療薬の組織への送達を高める方法及び組成物 |
| WO2002047725A2 (fr) | 2000-12-12 | 2002-06-20 | Debiopharm S.A. | Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation |
| US6476068B1 (en) * | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
| US20050142205A1 (en) * | 2003-07-18 | 2005-06-30 | Julia Rashba-Step | Methods for encapsulating small spherical particles prepared by controlled phase separation |
| CN101703467A (zh) | 2003-08-28 | 2010-05-12 | 梅恩医药有限公司 | 含有酸的奥沙利铂制剂 |
| KR100603974B1 (ko) | 2003-12-05 | 2006-07-25 | 김갑식 | 고체상 지질을 용매로 이용한 나노수준의 또는 비결정질입자의 제조 방법 |
| CN1775216A (zh) * | 2004-11-15 | 2006-05-24 | 胡才忠 | 一种新型的制剂——奥沙利铂脂质体 |
| DE102005011786A1 (de) * | 2005-03-11 | 2006-09-14 | Pharmasol Gmbh | Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen |
| BRPI0617663A2 (pt) * | 2005-10-21 | 2011-08-02 | Panacea Biotec Ltd | composições aperfeiçoadas para terapia de cáncer |
| KR20070067768A (ko) | 2005-12-23 | 2007-06-29 | 주식회사 삼양사 | 안정한 옥살리플라틴 조성물 및 이의 제조방법 |
| GR20060100144A (el) * | 2006-03-03 | 2007-10-17 | Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene | |
| KR101342119B1 (ko) | 2006-05-04 | 2013-12-18 | (주)바이오시네틱스 | 디올 화합물을 이용한 나노수준의 활성물질 입자 제조 방법 |
| JP4830019B2 (ja) * | 2006-05-04 | 2011-12-07 | バイオ−シネクティクス インク． | ナノスケールの活物質粒子の製造方法 |
| CN1868455A (zh) * | 2006-05-20 | 2006-11-29 | 沈阳药科大学 | 奥沙利铂磷脂复合物静脉给药的纳米混悬注射剂 |
| KR100913063B1 (ko) | 2006-09-13 | 2009-08-21 | 주식회사유한양행 | 옥살리플라틴-함유 주사용 용액 |
| JP2010515493A (ja) * | 2007-01-12 | 2010-05-13 | ヤンファン リー， | Ｘ線不透過性生物分解微小球型血管栓塞材料 |
| CN100563646C (zh) * | 2007-07-13 | 2009-12-02 | 陈祥峰 | 一种奥沙利铂脂质体葡萄糖制剂的制备方法 |
| US20100310661A1 (en) * | 2007-07-16 | 2010-12-09 | Poniard Pharmaceuticals, Inc. | Oral formulations for picoplatin |
-
2010
- 2010-09-20 IN IN2576DEN2012 patent/IN2012DN02576A/en unknown
- 2010-09-20 CA CA2774669A patent/CA2774669C/en not_active Expired - Fee Related
- 2010-09-20 MX MX2012003393A patent/MX348668B/es active IP Right Grant
- 2010-09-20 KR KR1020127003342A patent/KR101396461B1/ko not_active Expired - Fee Related
- 2010-09-20 EP EP10817463.2A patent/EP2481396A4/en not_active Withdrawn
- 2010-09-20 JP JP2012530778A patent/JP5759464B2/ja not_active Expired - Fee Related
- 2010-09-20 RU RU2012116085/15A patent/RU2563997C2/ru not_active IP Right Cessation
- 2010-09-20 CN CN201080052369.7A patent/CN102665689B/zh not_active Expired - Fee Related
- 2010-09-20 AU AU2010296180A patent/AU2010296180B2/en not_active Ceased
- 2010-09-20 US US13/497,208 patent/US9393201B2/en not_active Expired - Fee Related
- 2010-09-20 WO PCT/KR2010/006459 patent/WO2011034394A2/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010296180A1 (en) | 2012-04-19 |
| RU2563997C2 (ru) | 2015-09-27 |
| US9393201B2 (en) | 2016-07-19 |
| CA2774669C (en) | 2017-12-19 |
| CN102665689B (zh) | 2015-04-22 |
| AU2010296180B2 (en) | 2016-05-05 |
| WO2011034394A3 (ko) | 2011-11-03 |
| WO2011034394A2 (ko) | 2011-03-24 |
| MX2012003393A (es) | 2012-07-25 |
| JP2013505291A (ja) | 2013-02-14 |
| EP2481396A4 (en) | 2014-03-05 |
| EP2481396A2 (en) | 2012-08-01 |
| US20120177728A1 (en) | 2012-07-12 |
| CA2774669A1 (en) | 2011-03-24 |
| KR101396461B1 (ko) | 2014-05-20 |
| KR20120046243A (ko) | 2012-05-09 |
| CN102665689A (zh) | 2012-09-12 |
| RU2012116085A (ru) | 2013-10-27 |
| IN2012DN02576A (https=) | 2015-08-28 |
| MX348668B (es) | 2017-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102056596B (zh) | 纳米颗粒制剂及其用途 | |
| JP4334869B2 (ja) | 溶解性または経口吸収性の改善された組成物 | |
| JP5484910B2 (ja) | レバプラザン含有の固体分散体及びその製造方法 | |
| JP2021100968A (ja) | 新たな医薬組成物 | |
| CN102138903B (zh) | 一种依维莫司固体口服药物组合物 | |
| Yi et al. | The construction of puerarin nanocrystals and its pharmacokinetic and in vivo–in vitro correlation (IVIVC) studies on beagle dog | |
| JP2010533714A5 (https=) | ||
| JP5759464B2 (ja) | オキサリプラチンのナノ粒子及びその製造方法 | |
| ES2737955T3 (es) | Complejos de acetato de abiraterona, proceso para la preparación de los mismos y composiciones farmacéuticas que los contienen | |
| JP2018510221A (ja) | Ｐａｒｐ阻害剤固形医薬剤型及びその使用 | |
| Zhao et al. | Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions | |
| KR20190141270A (ko) | 아비라테론 아세테이트 제제 | |
| CN102048725A (zh) | 紫杉醇胆固醇复合物 | |
| Han et al. | A new approach to produce drug nanosuspensions CO2-assisted effervescence to produce drug nanosuspensions | |
| EP3616688A1 (en) | Preparation of nanosuspension comprising nanocrystals of active pharmaceutical ingredients with little or no stabilizing agents | |
| KR102490397B1 (ko) | 두타스테라이드를 포함하는 고형 제제 및 이의 제조방법 | |
| JP2020522580A (ja) | オキサリプラチンを含む経口用薬物送達組成物及びその製造方法 | |
| JPWO2006073154A1 (ja) | 医薬組成物及びその製造方法 | |
| CN101277681B (zh) | 微管蛋白抑制剂吲地布林的口服固体药物制剂 | |
| CN105997927A (zh) | 谷维素纳米结晶胶囊剂及其制备工艺 | |
| US20080171687A1 (en) | Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs | |
| CN113018268B (zh) | 一种注射用德拉沙星葡甲胺冻干制剂及其制备方法 | |
| KR20110029249A (ko) | 프란루카스트의 향상된 용해도를 갖는 약학적 조성물 | |
| KR20250100928A (ko) | 생체이용률이 개선된 엔잘루타마이드 약학 조성물 및 이의 제조방법 | |
| TWI619716B (zh) | 含維生素ｃ或其衍生物的替莫唑胺醫藥組成物及其製備方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130909 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140813 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141110 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150507 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150605 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5759464 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |